Efavirenz: Difference between revisions

>Unity
Grammatics and wording.
>Unity
Standardize and expand.
Line 3: Line 3:
{{SubstanceBox/Efavirenz}}
{{SubstanceBox/Efavirenz}}


'''Efavirenz''' (also known by the brand name '''Sustiva''') is a non-nucleotide reverse transcriptase inhibitor used in the treatment and prevention of human immunodeficiency virus infections type 1 (HIV-1). Efavirenz is notable for being able to produce [[psychedelic]] effects despite possessing an extremely novel pharmacological profile and chemical structure not shared with any other psychedelic.
'''Efavirenz''' (sold by the brand name '''Sustiva''') is an antiretroviral medication used in the treatment and prevention of HIV/AIDS.<ref>Vrouenraets, S. M., Wit, F. W., Tongeren, J. V., & Lange, J. M. (2007). Efavirenz: a review. Expert Opinion on Pharmacotherapy, 8(6), 851-871. https://doi.org/10.1517/14656566.8.6.851</ref> It is notable for being able to produce [[psychedelic]] and [[hallucinogenic]] effects despite possessing an extremely novel pharmacological profile and chemical structure not shared with any other psychedelic substance.
 
Efavirenz was approved for medical use in the United States in 1998.{{citation needed}} It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.<ref>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>
 
Recreational use of efavirenz for its hallucinogenic and dissociative effects has been reported in South Africa. It is used by crushing and smoking the tablets in a mixture known as ''whoonga'' and ''nyaope''.<ref>[http://news.bbc.co.uk/2/hi/africa/7768059.stm Getting high on HIV drugs in S Africa. BBC News, 8 December 2008.] {{webarchive|url=https://web.archive.org/web/20081209053431/http://news.bbc.co.uk/2/hi/africa/7768059.stm |date=9 December 2008 }}</ref><ref>[http://www.abcnews.go.com/Health/MindMoodNews/story?id=7227982&page=1 'No Turning Back': Teens Abuse HIV Drugs. ABC News, April 6, 2009.] {{webarchive|url=https://web.archive.org/web/20090408041457/http://abcnews.go.com/Health/MindMoodNews/story?id=7227982&page=1 |date=April 8, 2009 }}</ref><ref>[https://www.youtube.com/watch?v=W7BCi5ax7jk Getting High On HIV Medication] {{webarchive|url=https://web.archive.org/web/20140411153925/https://www.youtube.com/watch?v=W7BCi5ax7jk |date=2014-04-11 }} Vice 7.04.2014.</ref>


==Chemistry==
==Chemistry==
Unlike most psychedelics, efavirenz is not a [[tryptamine]], [[phenethylamine]] or [[lysergamide]]. Efavirenz is classified as a benzoxazine and has several different moieties which give it a unique pharmacological profile. On the two position of the benzoxazine ring, efavirenz has a ketone attached. Efavirenz also has a trifluoromethyl group as well as a cyclopropane ring.
Unlike most psychedelics, efavirenz is not a [[tryptamine]], [[phenethylamine]] or [[lysergamide]]. Efavirenz is classified as a benzoxazine and has several different moieties which give it a unique pharmacological profile. On the two position of the benzoxazine ring, efavirenz has a ketone attached. Efavirenz also has a trifluoromethyl group as well as a cyclopropane ring.
Efavirenz is a white to slightly pink crystalline powder with a molecular mass of 315.68 g/mol. It is practically insoluble in water (<10 µg/mL).{{citation needed}}


==Pharmacology==
==Pharmacology==